tiprankstipranks
C4 Therapeutics (CCCC)
NASDAQ:CCCC
US Market

C4 Therapeutics (CCCC) Income Statement

376 Followers

C4 Therapeutics Income Statement

Last quarter (Q4 2023), C4 Therapeutics's total revenue was $3.26M, an increase of Infinity% from the same quarter last year. In Q4, C4 Therapeutics's net income was $-34.75M. See C4 Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 20.76M$ 20.76M$ 31.10M$ 45.78M$ 33.20M$ 21.38M
Cost of Revenue
------
Gross Profit
$ 20.76M$ 20.76M$ 31.10M$ 45.78M--
Operating Expense
$ 159.79M$ 159.79M$ 160.63M$ -127.92M$ 93.64M$ 56.83M
Operating Income
$ -139.03M$ -139.03M$ -129.53M$ -82.13M$ -60.45M$ -35.45M
Net Non Operating Interest Income Expense
$ 9.21M$ 9.81M$ 3.58M$ -1.76M$ -836.00K$ 2.16M
Other Income Expense
$ -2.64M$ -2.04M$ 5.58M$ 788.00K$ -5.68M$ 325.00K
Pretax Income
$ -131.21M$ -131.21M$ -131.54M$ -84.68M$ -66.96M$ -33.30M
Tax Provision
$ 1.28M$ 1.28M--$ -626.00K$ 804.00K
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -129.94M$ -132.49M$ -131.54M$ -84.68M$ -66.33M$ -34.10M
Basic EPS
$ -2.67$ -2.67$ -2.62$ -1.82$ -5.83$ -2.31
Diluted EPS
$ -2.67$ -2.67$ -2.62$ -1.82$ -5.83$ -2.31
Basic Average Shares
$ 198.56M$ 49.64M$ 48.86M$ 46.04M$ 11.37M$ 14.79M
Diluted Average Shares
$ 198.56M$ 49.64M$ 48.86M$ 46.04M$ 11.37M$ 14.79M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 78.41M$ 159.79M$ 160.63M$ -127.92M$ 93.64M$ 56.83M
Net Income From Continuing And Discontinued Operation
$ -132.49M$ -132.49M$ -128.18M$ -84.68M$ -66.33M$ -34.10M
Normalized Income
$ -48.40M---$ -60.71M$ -34.10M
Interest Expense
----$ 1.23M$ 0.00
EBIT
$ -95.82M$ -130.21M$ -131.54M$ -82.92M$ -65.73M$ -33.30M
EBITDA
$ -67.78M$ -125.55M$ -122.54M$ -77.42M$ -64.11M$ -31.70M
Currency in USD

C4 Therapeutics Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis